Matthew R Schill1, Spencer J Melby1, Molly Speltz2, May Breitbach3, Richard B Schuessler1, Ralph J Damiano4. 1. Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri. 2. Scientific Solutions, LLC, Fridley, Minnesota. 3. Department of Surgery, Experimental Surgical Services, University of Minnesota, Minneapolis, Minnesota. 4. Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri. Electronic address: damianor@wustl.edu.
Abstract
PURPOSE: Cryoablation is used in the treatment of atrial fibrillation and other cardiac arrhythmias. This study evaluated a novel 10-cm flexible nitrous oxide cryoprobe in an ovine model of atrial ablation. DESCRIPTION: Six sheep were anesthetized, underwent a left thoracotomy, and were placed on cardiopulmonary bypass. A left atriotomy was performed, and the cryoprobe was applied endocardially for 120 seconds at less than -40°C to 4 sites on the left atrium. The atrium was closed and the animals were allowed to recover. After 30 days, the animals were euthanized. Transmurality was evaluated in 5-mm sections of each lesion using 2,3,5-triphenyltetrazolium chloride (TTC) and Masson's trichrome staining. EVALUATION: All animals survived. One hundred four of 106 sections (98%) were transmural by TTC; 103 of 106 (97%) sections were transmural by trichrome staining. There was no late atrial perforation, intraluminal thrombus, or thromboembolism. CONCLUSIONS: The device reliably produced transmural lesions in a chronic ovine model. Its performance was equivalent to that of other nitrous oxide cryoablation systems.
PURPOSE: Cryoablation is used in the treatment of atrial fibrillation and other cardiac arrhythmias. This study evaluated a novel 10-cm flexible nitrous oxide cryoprobe in an ovine model of atrial ablation. DESCRIPTION: Six sheep were anesthetized, underwent a left thoracotomy, and were placed on cardiopulmonary bypass. A left atriotomy was performed, and the cryoprobe was applied endocardially for 120 seconds at less than -40°C to 4 sites on the left atrium. The atrium was closed and the animals were allowed to recover. After 30 days, the animals were euthanized. Transmurality was evaluated in 5-mm sections of each lesion using 2,3,5-triphenyltetrazolium chloride (TTC) and Masson's trichrome staining. EVALUATION: All animals survived. One hundred four of 106 sections (98%) were transmural by TTC; 103 of 106 (97%) sections were transmural by trichrome staining. There was no late atrial perforation, intraluminal thrombus, or thromboembolism. CONCLUSIONS: The device reliably produced transmural lesions in a chronic ovine model. Its performance was equivalent to that of other nitrous oxide cryoablation systems.
Authors: James S Gammie; John C Laschinger; James M Brown; Robert S Poston; Richard N Pierson; Linda G Romar; Kimberly L Schwartz; Mary J Santos; Bartley P Griffith Journal: Ann Thorac Surg Date: 2005-09 Impact factor: 4.330
Authors: A Claire Watkins; Cindi A Young; Mehrdad Ghoreishi; Stephen R Shorofsky; Joel Gabre; Murtaza Y Dawood; Bartley P Griffith; James S Gammie Journal: Ann Thorac Surg Date: 2014-02-26 Impact factor: 4.330
Authors: Richard B Schuessler; Anson M Lee; Spencer J Melby; Rochus K Voeller; Sydney L Gaynor; Shun-Ichiro Sakamoto; Ralph J Damiano Journal: Heart Rhythm Date: 2009-12 Impact factor: 6.343
Authors: Sydney L Gaynor; Michael D Diodato; Sunil M Prasad; Yosuke Ishii; Richard B Schuessler; Marci S Bailey; Nicholas R Damiano; Jeffrey B Bloch; Marc R Moon; Ralph J Damiano Journal: J Thorac Cardiovasc Surg Date: 2004-10 Impact factor: 5.209
Authors: Ali J Khiabani; Robert M MacGregor; Joshua L Manghelli; Chawannuch Ruaengsri; Daniel I Carter; Spencer J Melby; Richard B Schuessler; Ralph J Damiano Journal: Ann Thorac Surg Date: 2020-06-06 Impact factor: 4.330